PMID- 31336471
OWN - NLM
STAT- MEDLINE
DCOM- 20191227
LR  - 20221207
IS  - 1878-0334 (Electronic)
IS  - 1871-4021 (Linking)
VI  - 13
IP  - 2
DP  - 2019 Mar-Apr
TI  - Visceral adiposity index in female with type 2 diabetic mellitus and its 
      association with the glycemic control.
PG  - 1241-1244
LID - S1871-4021(18)30669-6 [pii]
LID - 10.1016/j.dsx.2019.01.039 [doi]
AB  - AIMS: Visceral Adiposity Index (VAI) is suggested as a surrogate marker for 
      visceral adipose tissue dysfunction. It is an empirical-mathematical model, 
      sex-specific, based on metabolic and anthropometric parameters. Diabetes mellitus 
      is growing in an expanding fashion globally. The aim of this study to study the 
      association between VAI and glycemic control in women with type 2 diabetes 
      mellitus (T2DM). MATERIALS AND METHODS: A total of 300 T2DM female aged (25-60 
      years) were enrolled in this cross-sectional study. Subjects were recruited from 
      Baghdad medical city during the period from January 2017 to July 2018. Body mass 
      index (BMI), waist circumference (WC), blood pressure was measured and fasting 
      blood sample was analyzed for blood glucose, glycated hemoglobin(HbA1c), and 
      lipid profile. VAI was calculated in addition to triglyceride-glucose (TyG) 
      derived indices. Statistical analysis was done by SPSS version 23. The study was 
      ethically approved. RESULTS: Patients with high VAI showed poor glycemic control, 
      dyslipidemia, elevated TYG index, TYGWC and TYGBMI. The number of diabetics with 
      poor glycemic control increased across the VAI quartiles. The area under the 
      curve in ROC analysis demonstrated that VAI had a good predictive ability to 
      identify the state of glycemic control as compared to other anthropometric 
      measures (WC, BMI) or combined metabolic and anthropometric measures (TyGWC, 
      TyGBMI). CONCLUSION: increased VAI adversely affects the glycemic control in 
      women with T2DM.
CI  - Copyright (c) 2019 Diabetes India. Published by Elsevier Ltd. All rights reserved.
FAU - Hameed, Ekhlas Khalid
AU  - Hameed EK
AD  - The Clinical Biochemistry Department, Al-Kindy College of Medicine, University of 
      Baghdad, Baghdad, Iraq. Electronic address: ikhlaskhalid@yahoo.com.
FAU - AbdulQahar, Zina Hasan
AU  - AbdulQahar ZH
AD  - The Clinical Biochemistry Department, College of Medicine, University of Baghdad, 
      Baghdad, Iraq.
LA  - eng
PT  - Journal Article
DEP - 20190128
PL  - Netherlands
TA  - Diabetes Metab Syndr
JT  - Diabetes & metabolic syndrome
JID - 101462250
RN  - 0 (Biomarkers)
RN  - 0 (Blood Glucose)
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (hemoglobin A1c protein, human)
SB  - IM
MH  - *Adiposity
MH  - Adult
MH  - Biomarkers/*analysis
MH  - Blood Glucose/analysis
MH  - Cross-Sectional Studies
MH  - Diabetes Mellitus, Type 2/*complications
MH  - Female
MH  - Follow-Up Studies
MH  - Glycated Hemoglobin/analysis
MH  - Humans
MH  - Hyperglycemia/*diagnosis/epidemiology/etiology
MH  - Intra-Abdominal Fat/*physiopathology
MH  - Iraq/epidemiology
MH  - Male
MH  - Middle Aged
MH  - Obesity, Abdominal/*physiopathology
MH  - Prognosis
MH  - ROC Curve
MH  - Risk Factors
MH  - Waist Circumference
OTO - NOTNLM
OT  - Type 2 diabetes mellitus
OT  - Visceral adiposity
OT  - Visceral adiposity index
EDAT- 2019/07/25 06:00
MHDA- 2019/12/28 06:00
CRDT- 2019/07/25 06:00
PHST- 2018/12/30 00:00 [received]
PHST- 2019/01/22 00:00 [accepted]
PHST- 2019/07/25 06:00 [entrez]
PHST- 2019/07/25 06:00 [pubmed]
PHST- 2019/12/28 06:00 [medline]
AID - S1871-4021(18)30669-6 [pii]
AID - 10.1016/j.dsx.2019.01.039 [doi]
PST - ppublish
SO  - Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1241-1244. doi: 
      10.1016/j.dsx.2019.01.039. Epub 2019 Jan 28.